Caroline Thorn 5-12-11
bc6
bc6
e3a
af8
f37
af3
fff
b13
d16
e34
c19
a7e
c02
e68
c5d
aca
ff4
fbc
b13
b13
c92
bc6
cd2
b13
dc1
e61
c37
e0c
b13
eaa
f4c
18635746
PubMed
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
Drug Metab Dispos
2008
Kassner N
Huse K
Martin HJ
Gödtel-Armbrust U
Metzger A
Meineke I
Brockmöller J
Klein K
Zanger UM
Maser E
Wojnowski L
7954421
PubMed
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cancer Res
1994
Cole SP
Sparks KE
Fraser K
Loe DW
Grant CE
Wilson GM
Deeley RG
15164094
PubMed
Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.
Gene Ther
2004
Yagüe E
Higgins CF
Raguz S
12527936
PubMed
Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells.
Int J Oncol
2003
Singhal SS
Singhal J
Sharma R
Singh SV
Zimniak P
Awasthi YC
Awasthi S
11172691
PubMed
Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic.
Curr Med Chem
2001
Dantzig AH
Law KL
Cao J
Starling JJ
9333325
PubMed
Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin.
Biochemistry
1997
Vásquez-Vivar J
Martasek P
Hogg N
Masters BS
Pritchard KA Jr
Kalyanaraman B
12963485
PubMed
Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications.
Biochem Pharmacol
2003
Mordente A
Minotti G
Martorana GE
Silvestrini A
Giardina B
Meucci E
17559346
PubMed
Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients.
Pharmacogenomics
2007
Lal S
Wong ZW
Jada SR
Xiang X
Chen Shu X
Ang PC
Figg WD
Lee EJ
Chowbay B
2850270
PubMed
Reduction of oxygen by NADH/NADH dehydrogenase in the presence of adriamycin.
Free Radic Res Commun
1986
Thornalley PJ
Bannister WH
Bannister JV
7214365
PubMed
Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Cancer Res
1981
Tsuruo T
Iida H
Tsukagoshi S
Sakurai Y
3180056
PubMed
Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
Cancer Res
1988
Bellamy WT
Dalton WS
Kailey JM
Gleason MC
McCloskey TM
Dorr RT
Alberts DS
18616992
PubMed
Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3.
Toxicol Lett
2008
Novotna R
Wsol V
Xiong G
Maser E
17704753
PubMed
Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs.
Cancer Gene Ther
2007
Folmer Y
Schneider M
Blum HE
Hafkemeyer P
15054088
PubMed
The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage.
FASEB J
2004
Fogli S
Nieri P
Breschi MC
6305277
PubMed
Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity.
Arch Biochem Biophys
1983
Gutiérrez PL
Gee MV
Bachur NR
1911046
PubMed
Role of xanthine oxidase in the potentiation of doxorubicin-induced cardiotoxicity by mitomycin C.
Cancer Commun
1991
Gustafson DL
Swanson JD
Pritsos CA
10813659
PubMed
Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction.
Chem Res Toxicol
2000
Licata S
Saponiero A
Mordente A
Minotti G
12688675
PubMed
Differential ability of cytostatics from anthraquinone group to generate free radicals in three enzymatic systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase.
Oncol Res
2003
Pawłowska J
Tarasiuk J
Wolf CR
Paine MJ
Borowski E
10860924
PubMed
Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity.
Mol Pharmacol
2000
Niitsu N
Kasukabe T
Yokoyama A
Okabe-Kado J
Yamamoto-Yamaguchi Y
Umeda M
Honma Y
19442138
PubMed
New developments in anthracycline-induced cardiotoxicity.
Curr Med Chem
2009
Mordente A
Meucci E
Silvestrini A
Martorana GE
Giardina B
12370750
PubMed
Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.
Int J Oncol
2002
Nagata J
Kijima H
Hatanaka H
Asai S
Miyachi H
Abe Y
Yamazaki H
Nakamura M
Watanabe N
Mine T
Kondo T
Scanlon KJ
Ueyama Y
20007405
PubMed
Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism.
J Pharmacol Exp Ther
2010
Bains OS
Karkling MJ
Lubieniecka JM
Grigliatti TA
Reid RE
Riggs KW
1352877
PubMed
Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.
Proc Natl Acad Sci U S A
1992
Mechetner EB
Roninson IB
12751786
PubMed
Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses.
Biol Chem
2003
Miyamoto Y
Koh YH
Park YS
Fujiwara N
Sakiyama H
Misonou Y
Ookawara T
Suzuki K
Honke K
Taniguchi N
2544260
PubMed
Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.
Cancer Res
1989
Sinha BK
Mimnaugh EG
Rajagopalan S
Myers CE